• SCREENING

    Risk-adapted FIT screening intervals may personalize colorectal cancer screening

    A modeling study based on the BLITZ cohort suggests that screening intervals for fecal immunochemical tests could be tailored based on quantitative hemoglobin levels in initially negative tests, stratifying participants into low, medium, and high-risk groups. (BMC Med)